Interest Expense of Inozyme Pharma, Inc. from 31 Dec 2022 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inozyme Pharma, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Dec 2022 to 30 Jun 2024.
  • Inozyme Pharma, Inc. Interest Expense for the quarter ending 30 Jun 2024 was $1,395,000, a 81% increase year-over-year.
  • Inozyme Pharma, Inc. annual Interest Expense for 2023 was $3,333,000, a 1172% increase from 2022.
Source SEC data
View on sec.gov
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Inozyme Pharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,395,000 +$624,000 +81% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,325,000 +$997,000 +304% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q2 2023 $771,000 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $328,000 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1

Inozyme Pharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,333,000 +$3,071,000 +1172% 01 Jan 2023 31 Dec 2023 10-K 12 Mar 2024 2023 FY
2022 $262,000 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.